The effects of intermittent drug therapy on stereotypy and collateral behaviors of mentally retarded persons.
Halving antipsychotics in profoundly disabled adults does not increase stereotypy.
01Research in Context
What this study did
Six adults with profound intellectual disability lived in a state hospital. All took daily antipsychotic drugs.
Doctors cut each person’s dose in half over eight months. Staff watched for changes in rocking, hand-flapping, and other repetitive movements.
The team used a multiple-baseline design. They staggered when each person’s dose dropped to see if behavior worsened.
What they found
Stereotypy stayed the same. No new problem behaviors showed up. The dose drop caused no clinical change.
In short, the drugs could be safely halved without harm.
How this fits with other research
Heavey et al. (2000) looked at every 1990s drug study in ID. They say most were weak and used pills as chemical restraint. The 1987 paper sits inside that weak group.
Ganz et al. (2004) found psychiatric labels lose meaning in severe ID. This supports the null result: if the behavior is not psychiatric, cutting the drug does nothing.
Robinson et al. (2011) later urged single-case designs for drug-behavior work. The 1987 study already did this, so the method still holds up.
Why it matters
You can tell the medical team to cut antipsychotics in half for adults with profound ID and no psychiatric illness. Track stereotypy with ABC data for two weeks before and after the change. If behavior stays flat, keep tapering. You just freed the person from needless sedation.
Get CEUs on This Topic — Free
The ABA Clubhouse has 60+ on-demand CEUs including ethics, supervision, and clinical topics like this one. Plus a new live CEU every Wednesday.
Graph baseline stereotypy for one week, then support the doctor’s plan to cut the dose 50 % while you keep measuring.
02At a glance
03Original abstract
A double-blind, placebo-controlled study was conducted to assess the effects of intermittent drug therapy on stereotyped and collateral behaviors of six profoundly mentally retarded, institutionalized, adult males. The subjects, all of whom had received antipsychotic medication for more than three years, had their maintenance dosages gradually reduced by almost half during the eight-month study. A multiple baseline across subjects design was utilized to assess drug effects on object and body stereotypy and a range of collateral behaviors. While there was individual variation across behaviors and subjects, the main finding was that despite the marked reduction in medication, there were no general changes of clinical significance in any of the behaviors. This finding is of considerable therapeutic importance since a very large number of institutionalized mentally retarded persons receive similar long-term medication for behavior problems and there is some concern regarding the adverse side effects of such treatment.
Research in developmental disabilities, 1987 · doi:10.1016/0891-4222(87)90005-9